EU Commission releases pharma patent monitoring report
MLex Summary: Patent deals that see a transfer of value from the holder of a drug patent "transfer value" to a generic rival have decreased and stabilized at a low level,...To view the full article, register now.
Already a subscriber? Click here to view full article